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In adolescents with epilepsy, high scores of
anxiety and depression are associated with
occurrence of seizures in public places
Em adolescentes com epilepsia, altos escores de ansiedade e depressão foram
associados com ocorrência de crises em lugares públicos
Nathália F. Siqueira, Fernando L. B. B. Oliveira, Jorge A. Siqueira, Elisabete Abib Pedroso de Souza
ABSTRACT
Objective: To assess depression and anxiety symptoms of adolescents with epilepsy compared with adolescents without epilepsy.Method:
The study sample consisted of: case participants (50 subjects) attending the pediatric epilepsy clinic of a tertiary hospital and control
participants (51 subjects) from public schools. The instruments utilized were: identification card with demographic and epilepsy data, Beck
Depression Inventory and State-Trait Anxiety Inventory. Results: No significant differences were founded between the groups regarding
scores for depression and anxiety symptoms but both groups presented moderate scores of anxiety. A correlation was found between low
scores anxiety and not frequent seizures, low scores anxiety and perception of seizure control, high scores of anxiety and depression and
occurrence of seizures in public places. Conclusion: Low scores of anxiety are associated with not frequent seizures; high scores of anxiety
and depression are associated with occurrence of seizures in public places.
Keywords: epilepsy, adolescence, depression, anxiety, seizure frequency, perception of seizure control, occurrence of seizure in public
places.
RESUMO
Objetivo: O presente estudo teve como objetivo avaliar os sintomas de ansiedade e depressão de adolescentes com epilepsia comparados
com adolescentes sem epilepsia. Método: A amostra consistiu: grupo caso (50 indivíduos) atendidos no ambulatório de epilepsia infantil
do Hospital Universitário e grupo controle (51 indivíduos) de escolas públicas. Os instrumentos utilizados foram: cartão com dados
demográficos e de epilepsia, Beck Depression Inventory e State-Trait Anxiety Inventory. Resultados: Os resultados não mostraram
diferenças significativas entre os grupos em relação à depressão e ansiedade, mas ambos os grupos apresentaram escores moderados de
ansiedade. Foi encontrada correlação entre baixa pontuação de ansiedade e crises não frequentes e percepção de controle de crises; altas
pontuações de ansiedade e depressão e ocorrência de crises em lugares públicos. Conclusão: Variáveis psicossociais e da doença são
contingências importantes no comportamento adaptativo e controle do humor em uma doença crônica como a epilepsia.
Palavras-chave: epilepsia, adolescência, depressão, ansiedade, frequência de crises, percepção de controle de crises, ocorrência de crises
em público.
Epilepsy has been recognized as a risk factor for negative
outcomes in many aspects of the lives of people with this
diagnosis, including emotional, psychological, academic, and
social problems1. Prone to the social limitations that the dia-
gnosis of epilepsy brings, many people with epilepsy suffer
from moderate to severe depression and anxiety2.
Depression per se is one of the most commonly occurring
major psychiatric disorders, and it has become increasingly
recognized that the disease often begins in adolescence.
Depressive patients are often diagnosed with other illnesses,
especially anxiety and disruptive behavioral disorders3.
In adults with epilepsy depression and anxiety are the
most prevalent psychiatric disorders, affecting about 55% of
subjects4. In children and adolescents, many studies were also
carried out, developed with different designs and assessment
tools, and presenting diverse outcomes.
Ettinger et al.5 applied the quantitative scales Revised
Child Manifest Anxiety Scale (RCMAS)6 and Child Depression
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Inventory (CDI)7 to assess depression and anxiety in a popu-
lation of 44 children and adolescents ( from 7 to 18 years) with
epilepsy and found that 26% of patients had increased depres-
sion scores and 16% had anxiety symptomatology.
Dunn et al.8 studied adolescents with epilepsy aged 12-16
years in a cross-sectional design with 115 subjects and found
that 23% of those had symptoms of depression (based on the
CDI). Oguz et al.9 reported subjects aged 12-18 years to have
higher scores of depression (using the CDI) when compared
with a control group with normal children, but both of the
case groups (9-11 years and 12-18 years) showed increased
anxiety based on the State Trait Anxiety Inventory (STAI)10,
when compared with the control group.
Ott et al.11 investigated psychiatric illnesses in 114 chil-
dren with epilepsy aged 5-16 years and found that 61% of
the sample carried a psychiatric diagnosis, and, of those,
only a third was receiving adequate mental health treat-
ment. Caplan et al.12, with a similar sample (children with
epilepsy aged 5-16 years) and tool approach, but with a com-
parison control group, observed increased rates of affective
and anxiety disorders diagnoses (33% vs 6% - control) as well
as suicidal ideation (20% vs 9% - control) for the case group.
More recently, Loney et al.13 assessed anxiety and
depressive signs in children and adolescents from 7 to 17
years presenting at their clinic with a first seizure, using
CDI and RCMAS. For anxiety, there was a higher score for
case group versus published norms, but no difference when
compared with the control group; for depression, scores
were higher for case group when compared with both pub-
lished norms and control group.
Depression and anxiety in children and adolescents with
epilepsy requires further attention because it carries a risk of
reduced quality of life and complications in life14. Although
most studies agree that children and adolescents with epi-
lepsy have a high level of depression and anxiety, it is pos-
sible to perceive differences among the numbers presented
in these studies. Some of the reasons for the variability in
prevalence may include an inadequate consideration of both
biological and psychosocial factors15. These factors, includ-
ing the developmental stages of a person, may be related
to the subject age. The studies previously cited evaluated dif-
ferent age intervals, defined not by preexisting formal cri-
teria for the age range for children and age range for
adolescents, and their possible subdivisions16,17.
Moreover, the studies quoted took place in countries
such as USA, Turkey and Canada. Due to the very nature
of adolescence, a stage extremely affected by the envir-
onment, the previous studies may not be generalized or
applicable to a population of adolescents residing in a South
American developing country16.
With that in mind, the present study focused on a
defined population – adolescents with epilepsy belonging
to an age interval based on criteria from the World Health
Organization18 in Brazil not yet studied at this present time.
In this background, we aimed to assess, using available psy-
chological tools common to our service and different from
the ones used in the quoted studies, the scores of anxiety
and depression within the described population and com-
pare the results with a control group.
METHOD
Participants
The study sample consisted of 101 adolescents assessed
in the year 2011-2012. Case participants (50 subjects with
epilepsy) attended the pediatric Epilepsy Outpatient Depart-
ment of the University Hospital (UNICAMP, Campinas,
Brazil). Control participants (51 subjects without epilepsy)
were selected from public schools in Campinas-SP, Brazil.
The inclusion criteria were: age between 10 and 19 years,
according to the WHO criteria18, elementary and high school
education level, ability to answer the questions by himself/
herself, medical diagnosis of epilepsy for more than 2 years
(criteria established in service for epilepsy diagnosis) for
the group with epilepsy (case group) and no diagnosis of epi-
lepsy for the group without epilepsy (control group). The
exclusion criteria for both groups were: if they had had brain
surgery, used a concomitant medication with central nerv-
ous system effects (except the anticonvulsant used to treat
the epilepsy), or had another progressive neurological or psy-
chiatric illness.
Mean years of age of case group was 14.02 (Standard
Deviation (SD) = 1.99) and of control group was 12.63
(SD = 1.62); this difference was statistically significant
(p , 0.01). The majority of adolescents of the case group
were male (68%), students (96%), and attending elementary
school (72%). Most adolescents of control group were female
(58.82%), students (100%), and attending elementary school
(90.19%). The difference of gender was statistically signific-
ant (p = 0.007). For specific features of the case group, with
respect to medical data, most adolescents had focal seizures
(62%), had frequent seizures (56%), were on monotherapy
(58%), and mean of onset seizure was 6.4 years; with respect
to psychological variables, 84% of adolescents reported per-
ception of seizure control; and with respect to social aspects,
58% reported occurrence of seizures in public places.
Measures
1) Identification card with demographic data (age, sex,
education level, and job) for both groups and, for case group
only, epilepsy data (age of onset, seizure frequency, type of
seizure and drug treatment); all these data was collected
by the researcher that used medical records available at
the pediatric epilepsy clinic. Regarding frequency of seizures,
two groups were considered: frequent seizures (seizures that
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occur within one year) and not frequent seizures (patients
without seizures for one year). Type of seizure was classified
according to the International League Against Epilepsy clas-
sification of epileptic seizures19: focal seizures, generalized
seizures, focal + generalized seizures. Drug treatment was
classified in monotherapy (one type of medication) and poly-
therapy (two or more medications). Data on psychological
variable were also collected. Perception of seizure control
data was obtained through patient reports, in which they
evaluated whether their seizures were controlled or not;
these data were subjective and may reflect alterations in
the intensity and/or frequency of the seizures15. Patients
were also questioned if they had had occurrence of seizures
in public places (yes/no).
2) Beck Depression Inventory (BDI)20, validity and reli-
ability have been tested by Cunha21. The BDI includes a
21-item self-report was used to measure depression. Each
of the items contains a 4-point severity rating scale. The
scoring algorithm defines scores of 0-9 points as indicating
minimum depression; 10-16 points as indicating low de-
pression; 17-29 points as indicating moderate depression;
and 30-63 points as indicating major depression. The BDI
is being used as a standard reference and is one of the
most common self-report scales used to assess depression22
including in adolescents23.
3) State-Trait Anxiety Inventory (STAI)10 validated in
Portuguese language by Biaggio and Natalício24. The test is
divided in two sections: I - presents 20 statements related
to how the person feels most of the time (Trait); II - presents
20 statements related to how the person feels at the time of
assessment (State). To assess the level of trait anxiety and/or
state, it is necessary to first apply a correction to the scores
obtained on each item: the values of items 1, 6, 7, 10, 13, 16
and 19 of the Trait scale and 1, 2, 5, 8, 10, 11, 15, 16, 19 and 20
of the State scale must be inverted (in a way that 1 becomes
4, 2 becomes 3, 3 becomes 2 and 4 becomes 1). After that,
scores obtained on each item are summed up and classified
accordingly, to assess the level of anxiety: low, scores
between 20 and 34; moderate, scores between 35 and 49;
high, scores between 50 and 64; and very high, between 65
and 8025. STAI is widely used in monitoring anxiety states26
and is also an instrument used to assess anxiety in children
and adolescents10.
Procedure
Initially the Ethics Committee of Universidade Estadual
de Campinas (UNICAMP) approved the research (number
176/2005). After that, written informed consent was
obtained from all subjects and their companions (the one
with legal responsibility over the subject), on the day of
the outpatient consultation, in an interview to explain the
procedures. Subjects were assessed individually at the outpa-
tient clinic of Psychology Applied to Neurology at the
University Hospital of UNICAMP. On this first day, the
objective was to create a positive bond between the profes-
sional and subject (interview/presentation stage). On the
second day, one week later, the objective was to apply the
tools of research (the assessment stage). The selection of
subjects for the case group obeyed the demand of our neuro-
logy outpatient clinic, according to the criteria for inclusion
and exclusion, acceptance of the subject and responsibility
to take the research.
The selection of subjects of control group was according
to the criteria of inclusion and exclusion, acceptance of the
subject and responsibility to take the research. Two public
schools in Campinas-SP, Brazil, both of elementary and
high-school levels, were chosen by lottery. After the head-
master’s authorization, the students were taught about the
research and those who had an interest in participating took
the written informed consent home to get their parents’
signed authorization (interview or presentation stage). All
the adolescents of control group were assessed at the indi-
vidual class of their school, when the researcher returned to
the school to apply the tools of the research (assessment stage).
Statistics analysis
To describe the sample profile according to the study
variables, data was comprised of: categorical variables with
values of percentage (%), and descriptive statistics (with
measurements of position and dispersion - mean, standard
deviation, minimum, maximum and median) for continuous
variables (scores of scales).
To compare numerical variables between two groups we
used the Mann-Whitney test and Analysis of Covariance
(ANCOVA) when needed to adjust for age and sex.
The level of significance for statistical test was 5%
(p , 0.05).
RESULTS
Data on depression (BDI), state anxiety and trait anxiety
scores (STAI) from both groups is listed in Table 1.
Regarding symptoms of depression, no statistically sig-
nificant differences were found between the two groups.
On average, the case group was found in the minimum
depression sub-category while the control group was found
in the low depression sub-category (Table 1).
The absence of statistically significant differences between
the two groups was also a finding for anxiety symptoms
(Table 1).
Table 2 show correlations between frequency of seizures,
perception of seizure control, occurrence of seizure in public
places and STAI and BDI.
A statistically significant result was found in the correla-
tion between low trait and state anxiety versus not frequent
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seizures (medical data, p = 0.012 and p = 0.027, respectively).
Similar results were observed for low trait and state anxiety
versus perception of seizure control (psychological variable,
p = 0.039 and p = 0.010, respectively).
A statistically significant result was observed when cor-
relating occurrence of seizures in public places (social
aspect) with high depression scores (p = 0.046) and trait
anxiety (p = 0.003).
Despite the difference in the mean points, in terms of
percentages, the majority of adolescents from both case
group (72%) and control group (66%) remained in the min-
imum depression sub-category of the BDI (Figure 1).
In the trait anxiety component, the majority of adoles-
cents of both case group (56.86%) and control group
(47.05%) scored for moderate anxiety. In the state anxiety
component, the majority of adolescents from case group
scored for low anxiety (48%), and the majority of adolescents
from control group was divided between low and moderate
anxiety (43.13% each) (Figure 2).
DISCUSSION
In recent decades there has been a great interest in the
study of variables that control the impact of epilepsy, vari-
ables that go beyond the seizures. It has been noted the
importance of psychosocial and psychiatric conditions and
their influence in determining the well-being of individuals
in a chronic medical condition27.
First of all, our study showed that there were no stat-
istically significant differences between the group of
adolescents with epilepsy and control group when com-
paring depression scores and anxiety scores. These
new findings are particularly surprising, because epilepsy
was reported to correlate with high prevalence of depres-
sion and anxiety2,3,13. One must consider the conditions
that make difficult to compare the studies already
mentioned15. The use of different instruments, different
methodologies, characteristics of the population, form of
assessment tests, different countries in which the research
took place, and sub-categories analyzed may be factors
of variability.
In the demographic analysis of the groups, a statistically
significant difference was found; the subjects of case group
presented a mean age higher than the subjects in the control
group. Associated to this piece of information, we recall that
we found no statistically significant difference between the
scores of depression and anxiety for both groups even after
adjusting for age and sex. Considering the data altogether,
this higher age for case group may be related to a more
mature development state and to more access to mental
health treatment, as described by Ott et al.11 from his study,
it was found that children of older age were more likely to
have received mental health treatment. The access to treat-
ment may be related to a better knowledge of the disease
and, therefore, associated with better coping with the epi-
lepsy – leading to scores no different from the ones of the
control group.
In a chronic disease like epilepsy, the subject may be con-
trolled by different physical, psychological and social vari-
ables, contingencies that are linked to the manner with
which individuals perceive themselves and perceive their
relationship with the environment.
When our present results (scores of anxiety/depression)
were analyzed against the disease variables (medical, psy-
chological and social), meaningful correlations were observed.
Concerning frequency of seizures (medical data), the correla-
tions showed positive results between low frequency of
Figure 1. Depression in case group vs control group.
Figure 2. Anxiety in case group (state and trait domains) vs
control group (state and trait domains).
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seizures and low scores of trait and state anxiety. Perception
of seizure control (psychological variable) was positively cor-
related to low scores of trait and state anxiety. With regards to
occurrence of seizures in public places (social aspect), the cor-
relations showed positive results between high scores of
depression and trait anxiety and occurrence of seizures in
public places.
We could notice the conjugated influence of medical, psy-
chological and social variables in controlling the studied
adolescents’ responses. Such influence guides us to the
importance of the bio-psycho-social aspects for a better
comprehension of the human being in its totality.
Of all the factors that may influence the results we believe
that, from the psychological perspective, the development
Table 1. Results of Depression, Anxiety State and Anxiety Trait in case group and control group.
Dimensions Mean SD Minimum Median Maximum p-value* p-value**
Depression
Case group 6.30 6.20 0 4 19 0.321 0.316
Control group 10.10 11.40 0 6 52
State anxiety
Case group 36.20 8.90 20 35 67 0.529 0.267
Control group 37.50 9.40 23 36 60
Trait anxiety
Case group 40.00 8.80 23 39.5 60 0.886 0.881
Control group 40.50 10.50 26 39 65
SD: Standard deviation. *p-value referring to the test of Mann-Whitney to compare variables between groups (case group vs control group); **p-value
referring to the ANCOVA – covariates: age, sex.
Table 2. Correlations between frequency of seizures, perception of seizure control, occurence of seizure in public places and
STAI and BDI.
N Mean SD Minimum Median Maximum p-value*
Frequency of seizures
STAI – Trait anxiety
Frequent 28 42.64 8.06 27.00 41.50 57.00
Not frequent 22 36.59 8.65 23.00 37.00 60.00 0.012
STAI – State anxiety
Frequent 28 38.46 8.91 23.00 36.50 67.00
Not frequent 22 33.32 8.14 20.00 32.50 51.00 0.027
BDI
Frequent 28 7.32 6.32 0.00 6.50 29.00
Not frequent 22 5.05 5.91 0.00 3.00 21.00 0.116
Perception of seizure control
STAI – Trait anxiety
Controlled 42 38.93 8.52 23.00 38.00 60.00
Not controlled 08 45.50 8.51 29.00 47.00 57.00 0.039
STAI – State anxiety
Controlled 42 34.55 7.32 20.00 33.50 51.00
Not controlled 08 44.88 11.65 32.00 41.50 67.00 0.010
BDI
Controlled 42 5.50 5.07 0.00 3.00 21.00
Not controlled 08 10.63 9.60 0.00 9.00 29.00 0.221
Occurrence of seizures in public places
STAI – Trait anxiety
Yes 29 42.93 8.61 25.00 42.00 60.00
No 21 35.90 7.42 23.00 36.00 51.00 0.003
STAI – State anxiety
Yes 29 38.17 9.72 23.00 37.00 67.00
No 21 33.48 6.89 20.00 33.00 51.00 0.057
BDI
Yes 42 7.86 7.02 0.00 6.00 29.00
No 08 4.19 4.07 0.00 3.00 13.00 0.046
SD: Standard deviation; STAI: State-Trait Anxiety; BDI: Beck Depression Inventory. *p-value referring to the test of Mann-Whitney to compare variables.
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phases influence deserves to be discussed. Adolescence is a
life stage characterized by intense emotional and physical
transformation, and is determined by culture. These young
people are overwhelmed by intense feelings while going
through significant changes and assuming new behaviors29.
These significant changes may come laden with feelings of in-
adequacy, insecurity, loss of control, and fear of the unknown,
all of which can lead to the emergence of heightened anxiety
experiences. Since the majority of adolescents in both groups
had moderate scores of anxiety trait, we can assume that this
trait is inherent to the stage itself – adolescence -, regardless
of the disease – epilepsy.
Epilepsy patients have the perception of their illness
through their seizures. Souza and Salgado15 draw attention
to the perception of seizure control as an important factor
in the control of the disease, even if, from the medical per-
spective, the disease is not considered controlled. Patient may
have frequent seizures, but these decreased in the current per-
iod as he may deem it under control. According to the authors,
the positive perception of seizure control seems to be an
important factor to mitigate the impact of potentially stressful
experiences. The correlations between positive perception of
seizure control and low scores of anxiety found in our results
seem to support the influence of the psychological aspects that
control the well-being in this sample of adolescents.
These results are corroborated by recent studies with this
same population. Siqueira et al.27 investigated aspects that
show that these adolescents have good knowledge of epi-
lepsy, good social support perception, perception of seizure
control and no significant differences when compared with
a control group in rates of self esteem. Cancian30 observed
that the same adolescents with epilepsy seem to have better
coping with the disease. In this sense, it is possible to infer
that, in the status of a well-managed disease, epilepsy may
not be of great influence in the development of depression
and anxiety.
Our study had limitations. The sample was relatively
small, and restricted to one research center and country;
there was no randomization due to selection difficulties
and dropouts. Even though following the WHO criteria for
the classification of adolescence, the age range still showed
to be too large for the analysis of the results.
When considering the medical and psychosocial factors
of development, we suggest that future studies in this area
focus on analysis of age subcategories within the age range
previously established for adolescence, increased number of
subjects, different assessment tools and different settings for
must prove valuable in designing comprehensive and effect-
ive interventions to promote better social outcomes in ado-
lescence bearing this illness.
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